Phase 3 Lot Consistency Study of Trivalent Hemagglutinin Nanoparticle Influenza Vaccine
Clinical trial NCT06485752 · WITHDRAWN
Trial details
- NCT number
- NCT06485752
- Sponsor
- Novavax
- Status
- WITHDRAWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-01
- Primary completion
- 2025-02-04
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.